GSK · GB0009252882 · GSK | XLON | Prime AI Terminal

CUSIP

G3910J112

SEDOL

0925288

CIK

0001131399

gsk.com

LEI:

Securities Trading Warrants

From this overview you can obtain a wide range of company-specific data, primarily relating to the stock exchange listing and the associated identification in securities trading. If you need this and other information for other companies, you will find it here.

https://ayon.do/ts/940561

Smart Investor

Terminal

A
#	ID/ variable / content type	Security-specific parameter	UID	KB
1	ISIN INTERNATIONAL SECURITY IDENTIFICATION NUMBER	GB0009252882		Link
2	FIGI Financial Instrument Global Identifier®	BBG000H7K468		-
3	CIK Central Index Key	0001131399		Link
4	WKN WERTPAPIERKENNUMMER	940561		Link
5	SEDOL Stock Exchange Daily Official List	0925288		Link
6	CUSIP Committee on Uniform Securities Identification Procedures	G3910J112		Link
7	BLOOMBERG (default) BLOOMBERG IDENTIFIER	GSK LN		Link
8	RIC REUTERS/REFINITY IDENTIFIER	GSK.L		Link
9	MNEMONIC ABBREVIATION CODE	-		Link
10	TICKER TICKER	-		Link
11	SYMBOL SYMBOL	GSK		Link
12	TDIM Tradable Instrument Display Mnemonic	GSK		Link
13	MIC MARKET IDENTIFIER CODE	XLON		Link
14	DSX DOMESTIC STOCK EXCHANGE	LSE		Link
15	LEI LEGAL IDENTIFIER	-		Link
16	Valor Valor	-		-
17	CRN COMMERCIAL REGISTER NUMBER	-		Link
18	DNB-ID DUN & BRADSTREET	-		Link
19	VAT-ID VALUE ADDED TAX ID	-		-
20	GICS Global Industry Classification Standard®	-		-
21	Sector assignment GICS® Sector assignment	Drugs		-

gsk.com

Smart Investor

Terminal

B
#	ID/ variable / content type	Security-specific parameter	UID	KB
1	SHORT NAME -	GSK		-
2	LEGAL ENTITY NAME -	-		-
3	SECURITY NAME -	GlaxoSmithKline plc		-
4	NICKNAME -	-		-
5	PREVIOUS NAME -	-		-

Smart Investor

Terminal

C
#	ID/ variable / content type	Security-specific parameter	UID	KB
1	COUNTRY OF ORGIN	United Kingdom		-
2	ISO CODE 2 DIGIT ISO CODE	GB		-
3	ISO CODE 3 DIGIT ISO CODE	GBR		-
4	COUNTRY FLAG COUNTRY COLOUR CODE			-

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Page URL

Paste the page URL here

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .

I would like to remain anonymous.

Subject *

e.g. New calculation method for Risk-of-Ruin-Calculator

View/Tool *

This view/tool

Another page/tool

Description of the proposed change/feedback *

The more comprehensible the description, the faster a feasibility check can be carried out.

General feedback on the view/tool/component/content *

Use this feedback text field for general or supplementary information

Would you use the tool and recommend it if necessary? *

Your opinion is valuable. Feel free to share it with us.

GlaxoSmithKline plc

Newsletter